NCT00338000View on ClinicalTrials.gov

EPO-BUL-01 - Study of the Optimization of Anemia Management of EPREX (Epoetin Alfa) in Predialysis Patients With Chronic Renal Failure

PHASE4CompletedINTERVENTIONAL
Enrollment

292

Participants

Timeline

Start Date

June 30, 2001

Study Completion Date

May 31, 2005

Conditions
Chronic Renal Failure
Interventions
DRUG

Epoetin alfa

All Listed Sponsors
lead

Janssen Pharmaceutica N.V., Belgium

INDUSTRY

NCT00338000 - EPO-BUL-01 - Study of the Optimization of Anemia Management of EPREX (Epoetin Alfa) in Predialysis Patients With Chronic Renal Failure | Biotech Hunter | Biotech Hunter